Latest Federal Register Notices

Antimicrobial Drugs Panel to Discuss Product Development 04/07/2017
Federal Register notice: FDA announces a 4/13 Antimicrobial Drugs Advisory Committee meeting on developing antibacterial drugs that treat a single species of bacteria.

Workshop on Kidney Transplant Rejection Drugs 04/05/2017
Federal Register Notice: FDA announces a 4/12 public workshop on new developments and scientific issues related to antibody mediated rejection in kidney transplantation.

FDA/Xavier University Medical Device Conference 04/05/2017
Federal Register Notice: FDA co-sponsors with Xavier University a public conference entitled “FDA/Xavier University Medical Device Conference.”

Cedax Not Withdrawn Over Safety or Effectiveness 04/05/2017
Federal Register Notice: FDA determines that Pernix Therapeutics’ antibiotic Cedax (ceftibuten dihydrate) for oral suspension, 90mg/5mL and 180mg/5mL, were not withdrawn for reasons involving safety or effectiveness.